Myriad Genetics | MYGN - Operating Expenses

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.68

Myriad Genetics reported $212.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Illumina USD 903M 69M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veracyte USD 116M 7.24M Dec/2025
Waters USD 661.85M 1.67B Dec/2025